This study assessed the imaging outcomes of Liver Imaging Reporting and Data System (LI-RADS) v2018 category 2, 3, and 4 observations in prospective hepatocellular carcinoma (HCC) surveillance cohort. LI-RADS observations demonstrate increasing risk of progression to HCC with increasing category. About two-fifths of LR-4 progressed to a malignant category. LR-3 observations with APHE or threshold/subthreshold growth upgraded to LR-5 were significantly higher. Most LR-2 observations that remain stable in category for at least two years.
No takes yet. Share an insight, caveat, or question.
Xing et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: